Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.
Cancer Chemother Pharmacol
; 72(6): 1213-22, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24085260
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinazolinas
/
Receptor ErbB-2
/
Receptores ErbB
/
Neoplasias
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article